|Coronavirus Disease (COVID-19)|
Coronavirus Disease (COVID-19) Update
- Lawmakers already planning more coronavirus stimulus after $2T package
- The CDC says healthcare workers who can't get a mask should use a bandana or scarf as a 'last resort' as supplies run short
- CMS Fact Sheet: Expansion of the Accelerated and Advance Payments Program for Providers and Suppliers During Covid-19 Emergency
- Trump Administration Engages America’s Hospitals in Unprecedented Data Sharing
- FDA issues emergency authorization of anti-malaria drug for coronavirus care
- FDA issues an Emergency Use Authorization to Abbott Diagnostics Scarborough, Inc. for COVID-19 15-minute test
- Abbott Launches Molecular Point-Of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes
- Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices
- HHS Office for Civil Rights in Action Bulletin: Civil Rights, HIPAA, and the Coronavirus Disease 2019(COVID-19)
- House Speaker Nancy Pelosi (D-CA) has indeed confirmed that the House is already discussing its next major piece of legislation to help the country respond to the coronavirus public health emergency (PHE). Speaker Pelosi and other legislators from both the House and Senate are already describing what they hope to include in the “Phase IV” bill.
- Speaker Pelosi intends to strengthen Occupational Safety and Health Administration (OSHA) workplace protections for healthcare workers. These protections are in response to shortages of personal protective equipment (PPE) that has forced healthcare workers to use make-shift protective equipment such as trash bags and bandanas. The “Phase III” Cares Act did include some federal funding for OSHA and the Department of Labor for this purpose but Speaker Pelosi and other House Democrats believe more funding is needed. House Democrats included new OSHA protections for healthcare workers in their version of Phase III legislation. The Democratic version never received a vote.
- Congress is out of session until April 20th. The U.S. Capitol Building and its adjacent House and Senate Office Buildings are closed to the public until May 1st. Members and their Staff can still access the building for official business but many offices are teleworking.
White House and Federal Agencies
- President Trump extended his guidance for social distancing until at least April 30th. He previously advised that the social distancing guidance would continue until April 15th.
- The Centers for Medicare and Medicaid Services (CMS) is allowing Medicare providers to request Accelerated Advance payments for Medicare services. The purpose of this program is to help providers manage short-term cash flow issues.
- CMS regularly uses this policy in natural disasters. It is expanding the policy nationally during the public health emergency.
- Under the program, Medicare providers can receive payment for up to three months of Medicare payments. Providers can still bill for their services and will be paid as normal in addition to the advanced payments.
- Providers will repay the advanced payments back 120 days later. At the end of the 120-day period, the automatic recoupment process will begin and every claim submitted by the provider/supplier will be offset from the new claims to repay the accelerated/advanced payment. Instead of receiving payment for newly submitted claims, the provider’s/supplier’s outstanding accelerated/advance payment balance is reduced by the claim payment amount.
- CMS is asking hospitals to submit data on COVID-19 testing to HHS on a daily basis. Specifically, the Trump Administration is requesting that hospitals report COVID-19 testing data to the U.S. Department of Health and Human Services (HHS), in addition to daily reporting regarding bed capacity and supplies to the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) COVID-19 Patient Impact and Hospital Capacity Module.
- The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for hydroxychloroquine and chloroquine to treat COVID-19. Those drugs are intended to treat malaria but some studies have shown they can positively treat COVID-19. Additional studies to prove their efficacy in treating COVID-19 are ongoing. Manufacturers are beginning to donate doses to the Strategic National Stockpile which will distribute the drugs to the health systems across the country. Sandoz donated 30 million doses and Bayer donated 1 million doses.
- The FDA also issued and emergency use authorization for a testing device developed by Abbot Laboratories that can perform on-site COVID-19 tests and receive results within 15 minutes.
- The full list of FDA COVID-19 Emergency Use Authorizations (EUA) is available here. There are EUAs for ventilators, personal protective equipment (PPE), and testing/diagnostic devices.
- The HHS Office of Civil Rights (OCR) issued a bulletin reminding healthcare providers about non-discrimination requirements when treating patients for COVID-19.